Evidence map›Paper›PMID 34316558›Full record

ReviewInfection prevention in practice2020

Therapeutic management of patients with COVID-19: a systematic review.

M Tobaiqy, M Qashqary, S Al-Dahery, A Mujallad, A A Hershan, M A Kamal, N Helmi

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Infection prevention in practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 9 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 9 syntheses or guidelines pooled it, 238 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Psychological Health and Physical Activity Levels during the COVID-19 Pandemic: A Systematic Review.International journal of environmental research and public health · 2020
    Pooled it
  6. Is there any potential management against COVID-19? A systematic review and meta-analysis.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020
    Pooled it
  7. Pooled it
  8. Prophylactic anticoagulants for people hospitalised with COVID-19.The Cochrane database of systematic reviews · 2020
    Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M TobaiqyDepartment of Pharmacology, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
M QashqaryDepartment of Family Medicine, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
S Al-DaheryDepartment of Applied Radiologic Technology, College of Applied Medical Sciences, University of Jeddah, Jeddah, Saudi Arabia.
A MujalladDepartment of Nursing, College of Applied Medical Sciences, University of Jeddah, Jeddah, Saudi Arabia.
A A HershanDepartment of Medical Microbiology and Parasitology, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
M A KamalDepartment of Biochemistry, College of Science (Faculty of Science), University of Jeddah, Jeddah, Saudi Arabia.
N HelmiDepartment of Biochemistry, College of Science (Faculty of Science), University of Jeddah, Jeddah, Saudi Arabia.
Jeddah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which was declared a global pandemic by the World Health Organization on 11

aimTo report any evidence of therapeutics used for the management of patients with COVID-19 in clinical practice since emergence of the virus.

methodsA systematic review protocol was developed based on the PRISMA statement. Articles for review were selected from Embase, Medline and Google Scholar. Readily accessible peer-reviewed, full articles in English published from 1

resultsFour hundred and forty-nine articles were identified in the literature search; of these, 41 studies were included in this review. These were clinical trials (

conclusionsThis is the first systematic review to date related to medication used to treat patients with COVID-19. Only 41 studies were eligible for inclusion, most of which were conducted in China. Corticosteroid treatment was reported most frequently in the literature.

Indexed as

Arbidol hydrochlorideConvalescent plasma therapyCorticosteroidsCOVID-19HydroxychloroquineSARS-CoV-2

Identifiers

PMID34316558
PMCPMC7162768
OpenAlexW3017231304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.